RESUMO
Among nine compounds surveyed, cytidine was found to be the most effective in reversing the antiproliferative effects of cyclopentenyl cytosine (CPEC) on human T-lymphoblasts (MOLT-4) in culture. Cytidine, at concentrations of 1-25 microM, enabled cells to maintain normal logarithmic growth when added up to 12 hr after exposure to a 200 nM concentration of the oncolytic nucleoside, CPEC. The most abundant CPEC metabolite, CPEC-5'-triphosphate, is a potent [K1 approximately 6 microM] inhibitor of CTP synthetase (EC 6.3.4.2). Accumulation of this inhibitor resulted in a depletion of CTP levels to 17% of their original cellular concentration. Exogenous cytidine reversed CPEC-induced cellular cytotoxicity by suppressing the formation of CPEC-5'-triphosphate by 70%, and by partially replenishing intracellular CTP to at least 60-70% of its original concentration. In vivo, cytidine (500 mg/kg) administered intraperitoneally 4 hr after each daily dose of CPEC (LD10-LD100) for 9 days reduced the toxicity and abolished the lethality of CPEC to non-tumored mice. Of greater practical importance is the finding that, under these experimental conditions, cytidine did not curtail the antineoplastic properties of CPEC in L1210 tumor-bearing mice. Moreover, the concentration range over which CPEC exhibited antineoplastic activity was extended with cytidine administration.
Assuntos
Antineoplásicos/uso terapêutico , Citidina/análogos & derivados , Citidina/farmacologia , Leucemia L1210/tratamento farmacológico , Animais , Citidina/antagonistas & inibidores , Citidina/sangue , Citidina/uso terapêutico , Citidina/toxicidade , Citidina Trifosfato/análise , Interações Medicamentosas , Leucemia L1210/sangue , Masculino , Camundongos , Análise de Sobrevida , Células Tumorais CultivadasRESUMO
With increasing awareness of the mitochondrial toxicity associated with certain 2',3'-dideoxynucleosides used in anti-human immunodeficiency virus therapy, procedures for quantitative analyses of drug effects on mitochondrial DNA (mtDNA) have assumed enhanced importance. For this reason we have developed a method to measure the copy numbers of mtDNA in cultured MOLT-4 cells. First a hybrid competitive DNA template was synthesized by conventional polymerase chain reaction (PCR), using two custom-synthesized 40-mer composite primers incorporating mitochondrial displacement loop sequences linked by a non-mitochondrial cDNA template (a 76-base pair sequence from the tat/rev region of human immunodeficiency virus cDNA). For the competitive assay, increasing known copy numbers of the hybrid competitive template were added as an internal control to samples containing total cellular DNA. With this approach, two competitive PCR products were generated, 1) a mitochondrial displacement loop-derived fragment (182 base pairs) and 2) a competitive DNA template-derived fragment (156 base pairs). Absolute quantitation was achieved by radiometric comparison of the relative amounts of the two products. To test the versatility of this method, varying amounts of competitive template (6.6 x 10(4) to 6.6 x 10(9) copies) were used with a fixed quantity of total cellular DNA taken from cells cultured for 9 days in the presence or absence of selected pyrimidine and purine dideoxynucleosides. The results showed that the copy number of cellular mtDNA is 823 +/- 71 copies/cell in MOLT-4 cells. Little selective depletion of mtDNA, compared with total cellular DNA, was seen with the purine dideoxynucleosides examined; however, when the cells were exposed to the pyrimidine dideoxynucleoside 2',3'-dideoxycytidine (50 nM) for 9 days, mtDNA content was specifically depleted, although total cellular DNA decreased by only 10%. Thus, in addition to the presently used methods of assessing mitochondrial impairment, i.e., Southern blot analysis and electron microscopy, the competitive PCR method provides a third and convenient assay, with particular applicability to determination of mtDNA in very small numbers of cells.
Assuntos
DNA Mitocondrial/análise , Linfócitos/química , Reação em Cadeia da Polimerase/métodos , Sequência de Bases , Southern Blotting , Divisão Celular/efeitos dos fármacos , Células Cultivadas , DNA Mitocondrial/antagonistas & inibidores , Didanosina/análogos & derivados , Didanosina/farmacologia , Humanos , Dados de Sequência Molecular , Zalcitabina/farmacologiaRESUMO
We have examined a series of tyrosine kinase inhibitors structurally related to erbstatin (tyrphostins) for inhibition of p210bcr-abl autokinase activity in vitro and for growth inhibition of chronic myelogenous leukemia (CML)K562 cells. Of the tyrphostins with IC50 for growth < 50 microM, AG814, AG946, AG952, AG896, AG953, AG956 and AG957 (structurally related to lavendustin A and piceatannol) completely inhibited p210bcr-abl kinase activity in an immune complex kinase assay. Another group of tyrphostins (AG807, AG568, AG763, AG1076, AG490, AG1318, AG556, AG1319, AG555 and AG1111) inhibits growth of K562 cells but not p210bcr-abl tyrosine kinase activity. Of the compounds which inhibit growth and p210bcr-abl tyrosine kinase activity, AG957 inhibits DNA synthesis as early as 2 h (60% inhibition at 20 microM of AG957), a time and concentration of drug where RNA and protein synthesis were not affected. AG957 inhibits p210bcr-abl tyrosine phosphorylation in living cells by 1 h without an inhibition of total protein phosphorylation. Growth inhibition by AG957 was reversible after 4 h of exposure, but irreversible after 24 h. AG957 can be considered as an important lead structure for the development of anti-bcr-abl tyrosine kinase antagonists. These data also raise the possibility that bcr-abl kinase activity is directly linked to maintenance of DNA synthesis in Philadelphia chromosome positive (Ph+) CML cells.
Assuntos
Antineoplásicos/farmacologia , Catecóis/farmacologia , Proteínas de Fusão bcr-abl/antagonistas & inibidores , Leucemia Mielogênica Crônica BCR-ABL Positiva/metabolismo , Nitrilas/farmacologia , Proteínas Tirosina Quinases/antagonistas & inibidores , Tirfostinas , Trifosfato de Adenosina/metabolismo , DNA de Neoplasias/biossíntese , Humanos , Leucemia Mielogênica Crônica BCR-ABL Positiva/enzimologia , Proteínas de Neoplasias/biossíntese , Fosforilação , Testes de Precipitina , RNA Neoplásico/biossíntese , Células Tumorais CultivadasRESUMO
2',3'-Dideoxycytidine (ddCyd) is among the most potent of the anti-human immunodeficiency virus (HIV) agents of the dideoxynucleoside class. Its pharmacologically active metabolite 2',3'-dideoxycytidine 5'-triphosphate (ddCTP) is an effective inhibitor of HIV reverse transcriptase and thus of HIV replication. ddCyd differs, however, from other dideoxynucleoside agents such as 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in its capacity to generate phosphodiester metabolites (i.e. ddCDP choline and ddCDP ethanolamine). We have synthesized and characterized these two diesters, and established their identity with the metabolites formed in ddCyd-treated Molt-4 cells. Toward this end, the biologically generated metabolites have been isolated on a preparative scale and compared with the synthetic compounds mass spectroscopically, chromatographically, and enzymatically (i.e. their relative susceptibility to the catabolic enzymes alkaline phosphatase and venom phosphodiesterase). The concentration reached by each of these two phosphodiesters within cells can, under certain conditions, equal or exceed that of ddCTP, and their half-times of disappearance are long, indicating that they may serve as depot forms of ddCyd. The possible role of these phosphodiesters in contributing to the unusual toxicity of ddCyd is discussed.
Assuntos
Citidina Difosfato Colina/análogos & derivados , Nucleotídeos de Desoxicitosina/química , Etanolaminas/química , HIV/efeitos dos fármacos , Zalcitabina/metabolismo , Células Cultivadas , Colina/metabolismo , Cromatografia em Papel , Cistina Difosfato/análogos & derivados , Citidina Difosfato Colina/química , Citidina Difosfato Colina/metabolismo , Nucleotídeos de Desoxicitosina/metabolismo , Didesoxinucleotídeos , Etanolamina , Etanolaminas/metabolismo , Transcriptase Reversa do HIV , Estrutura Molecular , Inibidores da Transcriptase Reversa , Espectrometria de Massas de Bombardeamento Rápido de Átomos , Zalcitabina/farmacologiaRESUMO
Ten nutritionally variant streptococci were recovered from clinical specimens submitted to the Kansas State University Veterinary Clinical Bacteriology laboratory over a 4-year period. Isolates were recognized visually on primary blood agar plates by their satellite growth around a previously overlaid Staphylococcus aureus culture. All isolates grew within 24 hours in Todd-Hewitt and heart infusion broths supplemented with 5% bovine fetal serum and 5% S aureus filtrate. They also grew anaerobically in supplemented broths within 48 hours. However, isolates did not grow aerobically or anaerobically in the absence of supplements up to a 7-day postinoculation period. As determined by the standard Kirby-Bauer technique, the isolates were highly susceptible to antimicrobial agents commonly recommended in veterinary medicine. The isolates did not react with the corresponding Lancefield group-specific antisera, as tested by the capillary precipitin test.
Assuntos
Animais Domésticos/microbiologia , Streptococcus/isolamento & purificação , Anaerobiose , Animais , Antibacterianos/farmacologia , Antígenos de Bactérias/análise , Resistência Microbiana a Medicamentos , Variação Genética , Sorotipagem , Streptococcus/genética , Streptococcus/fisiologiaRESUMO
Oral and nasal fluids of 50 dogs were examined to determine the prevalence of aerobic bacteria frequently associated with animal bite wounds. The most frequently isolated microorganisms included: IIj, EF-4, Pasteurella multocida, Staphylococcus aureus, Staphylococcus epidermidis, group D streptococci, Corynebacterium sp., Enterobacteria, Neisseria sp., Moraxella sp., and Bacillus sp. Other species and genera were infrequently recovered and may represent transient flora. The high incidence of IIj, EF-4, P. multocida, and S. aureus, all known human pathogens, suggests that they should be considered as probably contaminants in bite wounds.
Assuntos
Bactérias/classificação , Mordeduras e Picadas/microbiologia , Muco/microbiologia , Mucosa Nasal/metabolismo , Saliva/microbiologia , Aerobiose , Animais , Cães , Resistência Microbiana a Medicamentos , Feminino , Humanos , MasculinoAssuntos
Bovinos , Fezes/microbiologia , Suínos , Animais , Bacillus/isolamento & purificação , Bacteroides/isolamento & purificação , Clostridium/isolamento & purificação , Corynebacterium/isolamento & purificação , Escherichia/isolamento & purificação , Feminino , Lactobacillus/isolamento & purificação , Streptococcus/isolamento & purificação , Leveduras/isolamento & purificaçãoAssuntos
Fenômenos Fisiológicos da Nutrição Animal , Gatos , Sistema Digestório/microbiologia , Aminoácidos/análise , Ração Animal/análise , Animais , Bacillus/isolamento & purificação , Bactérias/isolamento & purificação , Técnicas Bacteriológicas , Clostridium/isolamento & purificação , Carboidratos da Dieta/análise , Gorduras na Dieta/análise , Proteínas Alimentares/análise , Eletrólitos/análise , Enterobacteriaceae/isolamento & purificação , Escherichia/isolamento & purificação , Lactobacillus/isolamento & purificação , Pasteurella/isolamento & purificação , Proteus/isolamento & purificação , Staphylococcus/isolamento & purificação , Streptococcus/isolamento & purificação , Vitaminas/análiseAssuntos
Coagulação Sanguínea , Gatos/fisiologia , Bovinos/fisiologia , Cães/fisiologia , Cavalos/fisiologia , Animais , Anticoagulantes/farmacologia , Contagem de Células Sanguíneas , Coagulação Sanguínea/efeitos dos fármacos , Testes de Coagulação Sanguínea , Plaquetas , Citratos/farmacologia , Fator XI/análise , Fator XII/análise , Feminino , Masculino , Oxalatos/farmacologia , Fisiologia Comparada , Tempo de Protrombina , TromboplastinaRESUMO
Clinical pathological investigations in a case of equine isoerythrolysis are reported. Plasma and milk from the dam strongly agglutinated the foal's red blood cells at fifth day post partum. Red blood cells from one liter of the mare's blood were separated from plasma and after three successive washings with saline were successfully transfused into the foal. Elevated plasma transaminase activity, hypoglycemia, hypogammaglobinemia, and renal embarrassment were observed in this foal. The changes in the various plasma constituents are discussed.